UBS Group »

Psyence Biomedical shares owned by UBS Group

Quarter-by-quarter ownership of Psyence Biomedical (PBM) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Psyence Biomedical

23:59:59.999Dec 30, 202423:59:59.999500:00:00Dec 31, 202400:00:00.000500:00:00.00126.821k26.8215k26.822k26.8225k26.823k12.711k12.7115k12.712k12.7125k12.713k
Value ($)Share countHistorical PBM position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Psyence Biomedical held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Psyence Biomedical by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $27k 13k 2.11

More positions owned by UBS Group

Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
JPMorgan Chase & Co. Call Option (JPM)
Tesla Motors Call Option (TSLA)
Ubs Group SHS Call Option (UBS)
Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Tr Russell 2000 Etf (IWM)
Visa Com Cl A Call Option (V)

View all positions for UBS Group

Top funds holding Psyence Biomedical

Hudson Bay Capital Management
Essential Planning
AdvisorShares Investments
Hrt Financial
UBS Group
Virtu Financial
Citadel Advisors
Scientech Research
Connective Capital Management
Tower Research Capital

View all funds holding Psyence Biomedical